This report contains market size and forecasts of Bleeding Disorders in Global, including the following market information:
Global Bleeding Disorders Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Bleeding Disorders market was valued at 11130 million in 2020 and is projected to reach US$ 14110 million by 2027, at a CAGR of 6.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bleeding Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bleeding Disorders Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Bleeding Disorders Market Segment Percentages, By Type, 2020 (%)
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
China Bleeding Disorders Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Bleeding Disorders Market Segment Percentages, By Application, 2020 (%)
Hemophilia A
Hemophilia B
Others
Global Bleeding Disorders Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Bleeding Disorders Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Bleeding Disorders Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Bleeding Disorders Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bleeding Disorders Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bleeding Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bleeding Disorders Overall Market Size
2.1 Global Bleeding Disorders Market Size: 2021 VS 2027
2.2 Global Bleeding Disorders Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bleeding Disorders Players in Global Market
3.2 Top Global Bleeding Disorders Companies Ranked by Revenue
3.3 Global Bleeding Disorders Revenue by Companies
3.4 Top 3 and Top 5 Bleeding Disorders Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bleeding Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bleeding Disorders Players in Global Market
3.6.1 List of Global Tier 1 Bleeding Disorders Companies
3.6.2 List of Global Tier 2 and Tier 3 Bleeding Disorders Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bleeding Disorders Market Size Markets, 2021 & 2027
4.1.2 Plasma-derived Coagulation Factor Concentrates
4.1.3 Recombinant Coagulation Factor Concentrates
4.1.4 Desmopressin
4.1.5 Antifibrinolytics
4.1.6 Fibrin Sealants
4.1.7 Others
4.2 By Type - Global Bleeding Disorders Revenue & Forecasts
4.2.1 By Type - Global Bleeding Disorders Revenue, 2016-2021
4.2.2 By Type - Global Bleeding Disorders Revenue, 2022-2027
4.2.3 By Type - Global Bleeding Disorders Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bleeding Disorders Market Size, 2021 & 2027
5.1.2 Hemophilia A
5.1.3 Hemophilia B
5.1.4 Others
5.2 By Application - Global Bleeding Disorders Revenue & Forecasts
5.2.1 By Application - Global Bleeding Disorders Revenue, 2016-2021
5.2.2 By Application - Global Bleeding Disorders Revenue, 2022-2027
5.2.3 By Application - Global Bleeding Disorders Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Bleeding Disorders Market Size, 2021 & 2027
6.2 By Region - Global Bleeding Disorders Revenue & Forecasts
6.2.1 By Region - Global Bleeding Disorders Revenue, 2016-2021
6.2.2 By Region - Global Bleeding Disorders Revenue, 2022-2027
6.2.3 By Region - Global Bleeding Disorders Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Bleeding Disorders Revenue, 2016-2027
6.3.2 US Bleeding Disorders Market Size, 2016-2027
6.3.3 Canada Bleeding Disorders Market Size, 2016-2027
6.3.4 Mexico Bleeding Disorders Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Bleeding Disorders Revenue, 2016-2027
6.4.2 Germany Bleeding Disorders Market Size, 2016-2027
6.4.3 France Bleeding Disorders Market Size, 2016-2027
6.4.4 U.K. Bleeding Disorders Market Size, 2016-2027
6.4.5 Italy Bleeding Disorders Market Size, 2016-2027
6.4.6 Russia Bleeding Disorders Market Size, 2016-2027
6.4.7 Nordic Countries Bleeding Disorders Market Size, 2016-2027
6.4.8 Benelux Bleeding Disorders Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Bleeding Disorders Revenue, 2016-2027
6.5.2 China Bleeding Disorders Market Size, 2016-2027
6.5.3 Japan Bleeding Disorders Market Size, 2016-2027
6.5.4 South Korea Bleeding Disorders Market Size, 2016-2027
6.5.5 Southeast Asia Bleeding Disorders Market Size, 2016-2027
6.5.6 India Bleeding Disorders Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Bleeding Disorders Revenue, 2016-2027
6.6.2 Brazil Bleeding Disorders Market Size, 2016-2027
6.6.3 Argentina Bleeding Disorders Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bleeding Disorders Revenue, 2016-2027
6.7.2 Turkey Bleeding Disorders Market Size, 2016-2027
6.7.3 Israel Bleeding Disorders Market Size, 2016-2027
6.7.4 Saudi Arabia Bleeding Disorders Market Size, 2016-2027
6.7.5 UAE Bleeding Disorders Market Size, 2016-2027
7 Players Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Bleeding Disorders Major Product Offerings
7.1.4 Novo Nordisk Bleeding Disorders Revenue in Global (2016-2021)
7.1.5 Novo Nordisk Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Bleeding Disorders Major Product Offerings
7.2.4 Bayer Bleeding Disorders Revenue in Global (2016-2021)
7.2.5 Bayer Key News
7.3 Baxter International
7.3.1 Baxter International Corporate Summary
7.3.2 Baxter International Business Overview
7.3.3 Baxter International Bleeding Disorders Major Product Offerings
7.3.4 Baxter International Bleeding Disorders Revenue in Global (2016-2021)
7.3.5 Baxter International Key News
7.4 Alnylam Pharmaceuticals
7.4.1 Alnylam Pharmaceuticals Corporate Summary
7.4.2 Alnylam Pharmaceuticals Business Overview
7.4.3 Alnylam Pharmaceuticals Bleeding Disorders Major Product Offerings
7.4.4 Alnylam Pharmaceuticals Bleeding Disorders Revenue in Global (2016-2021)
7.4.5 Alnylam Pharmaceuticals Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Bleeding Disorders Major Product Offerings
7.5.4 Pfizer Bleeding Disorders Revenue in Global (2016-2021)
7.5.5 Pfizer Key News
7.6 Xenetic Biosciences
7.6.1 Xenetic Biosciences Corporate Summary
7.6.2 Xenetic Biosciences Business Overview
7.6.3 Xenetic Biosciences Bleeding Disorders Major Product Offerings
7.6.4 Xenetic Biosciences Bleeding Disorders Revenue in Global (2016-2021)
7.6.5 Xenetic Biosciences Key News
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Corporate Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Bleeding Disorders Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Bleeding Disorders Revenue in Global (2016-2021)
7.7.5 Bristol-Myers Squibb Company Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Bleeding Disorders Major Product Offerings
7.8.4 Sanofi Bleeding Disorders Revenue in Global (2016-2021)
7.8.5 Sanofi Key News
7.9 Janssen Global Services
7.9.1 Janssen Global Services Corporate Summary
7.9.2 Janssen Global Services Business Overview
7.9.3 Janssen Global Services Bleeding Disorders Major Product Offerings
7.9.4 Janssen Global Services Bleeding Disorders Revenue in Global (2016-2021)
7.9.5 Janssen Global Services Key News
7.10 Bioverativ
7.10.1 Bioverativ Corporate Summary
7.10.2 Bioverativ Business Overview
7.10.3 Bioverativ Bleeding Disorders Major Product Offerings
7.10.4 Bioverativ Bleeding Disorders Revenue in Global (2016-2021)
7.10.5 Bioverativ Key News
7.11 Amgen
7.11.1 Amgen Corporate Summary
7.11.2 Amgen Business Overview
7.11.3 Amgen Bleeding Disorders Major Product Offerings
7.11.4 Amgen Bleeding Disorders Revenue in Global (2016-2021)
7.11.5 Amgen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Bleeding Disorders Market Opportunities & Trends in Global Market
Table 2. Bleeding Disorders Market Drivers in Global Market
Table 3. Bleeding Disorders Market Restraints in Global Market
Table 4. Key Players of Bleeding Disorders in Global Market
Table 5. Top Bleeding Disorders Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bleeding Disorders Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bleeding Disorders Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bleeding Disorders Product Type
Table 9. List of Global Tier 1 Bleeding Disorders Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bleeding Disorders Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type